BPC-157 Injection Peptides Support Plan

This treatment plan outlines the dosage, administration, expected benefits, and potential side effects of BPC-157 (Body Protection Compound-157). Please read this plan carefully, along with the information provided with your medication, for complete details regarding precautions, handling, and other important safety information.

BPC-157 therapy is considered investigational and is typically used as part of a broader recovery or regenerative support plan.

For regenerative support, you have been prescribed:

BPC-157

Dosing:

• Inject 200 mcg daily
• 25 doses total (25-day course)

General guidance:

• Administer via subcutaneous injection (under the skin) unless otherwise directed
• Use a new sterile needle and syringe for each injection
• Rotate injection sites (commonly abdomen or near the affected area, if directed)
• Use the exact prescribed dose and schedule
• Do not exceed the recommended dose
• Store medication as directed (commonly refrigerated after reconstitution)
• Do not use if the solution appears cloudy or contains particles

BPC-157 works gradually and does not produce immediate symptomatic effects. Response varies depending on individual factors and treatment goals.

Use only as prescribed. Do not increase your dose or frequency without provider guidance.

BPC-157 is considered investigational and is not FDA-approved for the treatment of specific medical conditions.

Possible side effects may include mild injection site irritation, redness, or discomfort.

Because large-scale human studies are limited, long-term safety is not fully established.

If you experience unusual or persistent symptoms, discontinue use and contact your provider.

Do not use this medication if it has been improperly stored or appears compromised.

Do not share this medication or use it outside of medical supervision.

This medication contains the following active ingredient. Do not use if you are allergic to this ingredient or any components provided with the medication.

• BPC-157

Allergic reactions are uncommon but possible.

Stop this medication and seek medical care if you experience:

• Rash or hives
• Swelling of the face, lips, or throat
• Difficulty breathing
• Severe injection site reaction

We evaluate your health history based on the information you provide. If any of the following apply or develop during treatment, discontinue use and seek in-person evaluation:

• Known hypersensitivity to peptide therapies
• Active infection at injection site
• Unexplained systemic symptoms
• Pregnancy or breastfeeding (safety not established)
• Significant underlying medical conditions without provider clearance

We evaluate the specific health information you provide and make our recommendations based on it. If you incorrectly provide that information, we may misdiagnose or fail to diagnose conditions that you may have which could affect our recommendation for treatment.

We recommend this treatment because the potential benefits of treatment outweigh the risks. You should evaluate this information as well as the manufacturer’s pamphlet, and any input from your in-person healthcare team, or other information to decide if this treatment plan is appropriate for you. You are free to decline our treatment recommendations although, doing so may prolong symptoms and be associated with negative outcomes.

We have based our recommendation on your specific case and medical guidelines, but there may be alternative treatments or strategies that may be helpful to you. Some may be more or less effective than what we provide. Some treatments may require an in-person exam or procedure which we can’t provide.

You can access your records anytime. We strongly recommend that you update your in-person doctor, pharmacist, and the rest of your healthcare team to let them know about any new medicines you are taking or other changes in your health.